ASHLAND INC.
Close on Oct 19, 2026
- Market cap
- $3.27K
- P/E (TTM)
- –
- Dividend yield
- 2.30%
About Ashland
Wholesale-Chemicals & Allied Products, SIC 5160
Ashland Inc. produces specialty additives and functional ingredients for consumer and industrial applications across four operating segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. Life Sciences provides pharmaceutical polymers and nutritional formulation ingredients to drug manufacturers, healthcare facilities, and food producers. Personal Care supplies nature-derived ingredients, active compounds, and specialty polymers to consumer brands for skin care, hair care, oral care, and cleaning products. Specialty Additives manufactures performance-enhancing additives and rheology modifiers for paint, construction, and energy companies. The Intermediates segment produces 1,4 butanediol and chemical solvents for industrial, polymer, and electronic manufacturing.
The business operates across the Americas, Europe, and the Asia Pacific region, marketing its products in more than 100 countries. It maintains manufacturing and laboratory facilities in countries such as the United States, Brazil, China, Germany, and India, with additional derivative production in Texas and Kentucky. Ashland employs approximately 2,900 people worldwide and maintains its principal executive offices in Wilmington, Delaware.
Summary of the business section of Ashland's latest annual report, written by StockData.
Company profile
Company
- Legal name
- ASHLAND INC.
- Founded
- 1924
- Headquarters
- Wilmington, DE
- Address
- 8145 Blazer Drive 19808
- Phone
- (304) 995-3000
- Website
- ashland.com
- Employees
- 2,900, Sep 30, 2025
- Industry
- Wholesale-Chemicals & Allied Products
- Incorporated in
- Delaware
- Fiscal year ends
- September 30
- Auditor
- Ernst & Young LLP, Grandview Heights, Ohio
Stock & identifiers
- Ticker
- ASH
- Exchange
- NYSE
- Shares outstanding
- 46M, Jun 30, 2026
- Public float
- $2.70B, Mar 31, 2025
- Filer category
- Large accelerated filer
- Stock splits
- 2-for-1, Jul 29, 1988
- SEC CIK
- 1674862
- CUSIP
- 044186104
- ISIN
- US0441861046
- LEI
- 529900E4L9R04SB8HB11
- EIN
- 81-2587835
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Guillermo Novo | Chair of the Board and CEO, Director | 172,143 |
| Osama M. Musa | SVP and CTO | 37,577 |
| Robin E. Lampkin | SVP, GC & Secretary | 7,690 |
| Alessandra Faccin Assis | SVP and GM, Life Sciences | 9,099 |
| James P. Minicucci | SVP and GM, Personal Care | 8,567 |
| William Whitaker | SVP, CFO & PFO | 2,082 |
| Eileen Drury | SVP and Chief HRO | 7,601 |
| Dago Caceres | SVP & GM, Specialty Additives | 746 |
| Samuel Richardson | VP, Controller and PAO | 1,072 |
| Eric N. Boni | VP, Finance & Prinpl Acctg Off | 22,770 |
| J. Kevin Willis | SVP and CFO | 270,566 |
| Karl R. Bostaph | Senior VP Operations | 7,165 |
| Allen A. Spizzo | Director | – |
| Peter T. Thomas | Director | 4,500 |
| Steven D. Bishop | Director | – |
| Sanat Chattopadhyay | Director | – |
| Bertrand Loy | Director | – |
| Ashish K. Kulkarni | Director | 2,113 |
| Suzan F. Harrison | Director | 1,931 |
| Sue Main | Director | 1,883 |
| Jerome A. Peribere | Director | 1,883 |
| Scott Tozier | Director | – |
| Sergio Pedreiro | Director | – |
| Janice Teal | Director | 1,883 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 | $7.87M | -$2.86M | $2.27M | $74 | $129 |
| FY2024 | $8.73M | $12.25M | $2.74M | $130 | $154 |
| FY2023 | $6.97M | $239.76K | $2.18M | $120 | $135 |
| FY2022 | $9.32M | $12.90M | $2.07M | $137 | $114 |
| FY2021 | $7.60M | $9.13M | $1.72M | $127 | $128 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“As of September 30, 2025, Ashland had approximately 2,900 employees in more than 100 countries.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Jul 28, 2022 | Name change | Name changed from ASHLAND GLOBAL HOLDINGS INC to ASHLAND INC. |
| Mar 3, 2022 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Feb 28, 2022 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Sep 3, 2019 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| May 18, 2017 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| May 12, 2017 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Sep 20, 2016 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| May 31, 2016 | Merger | Registration of securities for a merger or exchange offer (S-4) |